Aktis Oncology to Present at the BofA Securities Health Care Conference
Aktis Oncology announced that CEO Matthew Roden will present at the BofA Securities Health Care Conference in Las Vegas on May 13, 2026. The company is a clinical-stage oncology firm focused on targeted radiopharmaceuticals, with lead programs AKY-1189 (targeting Nectin-4) and AKY-2519 (targeting B7-H3).
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.